Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARCELA MAZO-CANOLA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1801116462
CMS profile
1571619
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$97,086.87

75 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $47,716.84 29
AstraZeneca Pharmaceuticals LP $31,835.03 24
Stemline Therapeutics Inc. $14,635.99 13
TerSera Therapeutics LLC $2,746.34 7
Daiichi Sankyo Inc. $122.02 1
PFIZER INC. $30.65 1

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

75 matching records · $97,086.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 75 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 75.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Stemline Therapeutics Inc. $310.0012/26/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261244098480 CMS
AstraZeneca Pharmaceuticals LP $820.0012/11/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261207005061 CMS
AstraZeneca Pharmaceuticals LP $118.6512/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206379884 CMS
Gilead Sciences, Inc. $1,980.0012/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261234357188 CMS
AstraZeneca Pharmaceuticals LP $6,560.0011/25/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261206456364 CMS
Gilead Sciences, Inc. $452.3811/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261234366265 CMS
AstraZeneca Pharmaceuticals LP $259.5011/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206284104 CMS
AstraZeneca Pharmaceuticals LP $755.8611/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206621001 CMS
AstraZeneca Pharmaceuticals LP $259.5011/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206746078 CMS
AstraZeneca Pharmaceuticals LP $6.9911/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206815608 CMS
AstraZeneca Pharmaceuticals LP $225.6311/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206837231 CMS
AstraZeneca Pharmaceuticals LP $458.9611/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261207063462 CMS
AstraZeneca Pharmaceuticals LP $39.7111/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261207301936 CMS
AstraZeneca Pharmaceuticals LP $6,560.0011/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261206665487 CMS
Stemline Therapeutics Inc. $4,030.0010/31/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261244098471 CMS
AstraZeneca Pharmaceuticals LP $111.8410/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206609410 CMS
AstraZeneca Pharmaceuticals LP $808.6710/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206658426 CMS
AstraZeneca Pharmaceuticals LP $109.6510/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206999232 CMS
AstraZeneca Pharmaceuticals LP $406.9710/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261207165775 CMS
AstraZeneca Pharmaceuticals LP $112.0310/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206305527 CMS
Daiichi Sankyo Inc. $122.0210/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261197032157 CMS
Gilead Sciences, Inc. $5,140.0010/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261234353735 CMS
Stemline Therapeutics Inc. $92.3110/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244098429 CMS
Gilead Sciences, Inc. $987.7210/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261234363853 CMS
Stemline Therapeutics Inc. $358.3610/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244098462 CMS
Gilead Sciences, Inc. $147.3410/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234376212 CMS
Gilead Sciences, Inc. $3,950.0009/26/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261234354301 CMS
TerSera Therapeutics LLC $70.0009/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244059404 CMS
TerSera Therapeutics LLC $78.0009/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244059406 CMS
TerSera Therapeutics LLC $270.0209/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244059408 CMS
TerSera Therapeutics LLC $2,000.0009/26/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261244059410 CMS
TerSera Therapeutics LLC $132.0009/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244059412 CMS
TerSera Therapeutics LLC $19.9109/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244059414 CMS
TerSera Therapeutics LLC $176.4109/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244059416 CMS
Stemline Therapeutics Inc. $270.5909/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244098436 CMS
Stemline Therapeutics Inc. $28.1409/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244098475 CMS
Gilead Sciences, Inc. $121.3609/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234389666 CMS
Stemline Therapeutics Inc. $761.3509/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244098433 CMS
AstraZeneca Pharmaceuticals LP $6,560.0009/19/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261206389212 CMS
AstraZeneca Pharmaceuticals LP $732.6509/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261206384388 CMS
AstraZeneca Pharmaceuticals LP $121.8609/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206749297 CMS
Stemline Therapeutics Inc. $1,550.0008/22/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261244098467 CMS
Gilead Sciences, Inc. $3,950.0008/20/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261234354299 CMS
Gilead Sciences, Inc. $121.1608/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234389916 CMS
Gilead Sciences, Inc. $3,950.0007/31/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261234354297 CMS
PFIZER INC. $30.6507/16/2025 Education No dispute reported Delay: No
Change: NEW
06/30/20261230195625 CMS
AstraZeneca Pharmaceuticals LP $1,640.0007/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261206856763 CMS
Stemline Therapeutics Inc. $3,100.0007/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261244098447 CMS
Stemline Therapeutics Inc. $120.0007/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244098453 CMS
Stemline Therapeutics Inc. $235.2007/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261244098457 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $745.21 56
PY2020 $524.13 32
PY2021 $245.75 13
PY2022 $3,261.29 9
PY2023 $61,652.32 62
PY2024 $93,046.50 90
PY2025 $97,086.87 75

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MARCELA MAZO-CANOLA, NPI 1801116462. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1801116462.
APA 7
IndustryPayments. (2026). MARCELA MAZO-CANOLA, NPI 1801116462 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1801116462
Bluebook
MARCELA MAZO-CANOLA, NPI 1801116462, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1801116462.

Source: Centers for Medicare & Medicaid Services, Open Payments.